Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.6M | Buy |
1,341,471
+68,402
| +5% | +$1.82M | 0.03% | 201 |
|
|
2025
Q4 | $31.8M | Sell |
1,273,069
-1,224,673
| -49% | -$30.9M | 0.03% | 220 |
|
|
2025
Q3 | $63.1M | Buy |
2,497,742
+618,597
| +33% | +$15.3M | 0.06% | 155 |
|
|
2025
Q2 | $45.6M | Buy |
1,879,145
+290,657
| +18% | +$6.78M | 0.05% | 174 |
|
|
2025
Q1 | $40.2M | Buy |
1,588,488
+160,217
| +11% | +$4.19M | 0.05% | 180 |
|
|
2024
Q4 | $37.9M | Buy |
1,428,271
+27,188
| +2% | +$737K | 0.04% | 179 |
|
|
2024
Q3 | $40.5M | Sell |
1,401,083
-31,144
| -2% | -$909K | 0.04% | 188 |
|
|
2024
Q2 | $39.8M | Buy |
1,432,227
+647,281
| +82% | +$17.8M | 0.04% | 180 |
|
|
2024
Q1 | $21.8M | Sell |
784,946
-1,278,680
| -62% | -$35.5M | 0.02% | 248 |
|
|
2023
Q4 | $59.4M | Buy |
2,063,626
+456,912
| +28% | +$13.8M | 0.07% | 152 |
|
|
2023
Q3 | $53.3M | Buy |
1,606,714
+573,196
| +55% | +$20.3M | 0.08% | 143 |
|
|
2023
Q2 | $37.9M | Buy |
1,033,518
+22,276
| +2% | +$867K | 0.06% | 179 |
|
|
2023
Q1 | $41.2M | Sell |
1,011,242
-2,942,564
| -74% | -$127M | 0.07% | 167 |
|
|
2022
Q4 | $203M | Sell |
3,953,806
-3,948,816
| -50% | -$189M | 0.35% | 61 |
|
|
2022
Q3 | $346M | Buy |
7,902,622
+2,003,470
| +34% | +$97.4M | 0.65% | 45 |
|
|
2022
Q2 | $309M | Buy |
5,899,152
+3,781,229
| +179% | +$193M | 0.56% | 48 |
|
|
2022
Q1 | $110M | Sell |
2,117,923
-10,157,575
| -83% | -$527M | 0.16% | 88 |
|
|
2021
Q4 | $717M | Buy |
12,275,498
+10,475,749
| +582% | +$519M | 1.02% | 28 |
|
|
2021
Q3 | $77.4M | Sell |
1,799,749
-348,002
| -16% | -$15.4M | 0.12% | 112 |
|
|
2021
Q2 | $84.1M | Buy |
2,147,751
+1,029,249
| +92% | +$40M | 0.14% | 109 |
|
|
2021
Q1 | $40.5M | Sell |
1,118,502
-193,888
| -15% | -$6.88M | 0.07% | 170 |
|
|
2020
Q4 | $48.2M | Sell |
1,312,390
-232,127
| -15% | -$8.51M | 0.1% | 140 |
|
|
2020
Q3 | $53.8M | Sell |
1,544,517
-8,009
| -0.5% | -$281K | 0.13% | 122 |
|
|
2020
Q2 | $48.2M | Buy |
1,552,526
+26,174
| +2% | +$889K | 0.13% | 111 |
|
|
2020
Q1 | $47.3M | Buy |
1,526,352
+380,656
| +33% | +$13M | 0.16% | 106 |
|
|
2019
Q4 | $42.3M | Sell |
1,145,696
-1,098,770
| -49% | -$39.1M | 0.11% | 124 |
|
|
2019
Q3 | $76.5M | Sell |
2,244,466
-411,591
| -15% | -$15M | 0.23% | 92 |
|
|
2019
Q2 | $109M | Sell |
2,656,057
-72,014
| -3% | -$2.86M | 0.34% | 74 |
|
|
2019
Q1 | $110M | Sell |
2,728,071
-7,249,475
| -73% | -$290M | 0.36% | 75 |
|
|
2018
Q4 | $407M | Buy |
9,977,546
+1,363,944
| +16% | +$56.6M | 1.58% | 12 |
|
|
2018
Q3 | $360M | Sell |
8,613,602
-408,792
| -5% | -$15.7M | 1.28% | 13 |
|
|
2018
Q2 | $311M | Sell |
9,022,394
-1,306,354
| -13% | -$44.6M | 1.15% | 21 |
|
|
2018
Q1 | $347M | Buy |
10,328,748
+407,381
| +4% | +$14M | 1.34% | 12 |
|
|
2017
Q4 | $341M | Buy |
9,921,367
+414,705
| +4% | +$14.1M | 1.31% | 15 |
|
|
2017
Q3 | $322M | Buy |
9,506,662
+182,482
| +2% | +$5.86M | 1.34% | 14 |
|
|
2017
Q2 | $297M | Sell |
9,324,180
-82,238
| -0.9% | -$2.59M | 1.38% | 10 |
|
|
2017
Q1 | $305M | Buy |
9,406,418
+6,447
| +0.1% | +$203K | 1.39% | 10 |
|
|
2016
Q4 | $290M | Buy |
+9,399,971
| New | +$287M | 1.4% | 9 |
|
Other funds holding PFE
VCM
VPM
DZ Bank's PFE Position: Q1 2026 in Review
DZ Bank increased its Pfizer (PFE) stake by 5.4% in Q1 2026, buying an estimated $1.82M and bringing the position to 1,341,471 shares worth $37.6M. The position accounts for 0.03% of the portfolio, ranked #201.
DZ Bank first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $717M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- DZ Bank held 1,341,471 shares of Pfizer worth $37.6M as of Q1 2026.
- DZ Bank bought 68,402 Pfizer shares in Q1 2026, an estimated $1.82M.
- Pfizer made up 0.03% of DZ Bank's portfolio in Q1 2026, its #201 holding.
- DZ Bank first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- DZ Bank's Pfizer position peaked at $717M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.